Kalvista pharmaceuticals inc

Major-Pharmaceuticals

KALV


55 Cambridge Parkway
Cambridge , MA 02142

Executive/
Director

Price

  • Last Close
  • $ 9.46
    $ +0.1 1.07 %
    Dec 10, 2024
  • 52-Week High/Low
  • $16.04 - $7.58
  • YTD
  • -22.8%

  • Trading Volume
  • 11,467
  • Market Cap Full
  • $ 326.9M
  • Shares Outstanding
  • 34.6M
    Nov 30, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - 10.5% -2.8% 44.9% -5% 40.9% 11.4% 16.3% -3.2%
Q2 - - -5.8% -11.2% -21.7% 4% -8.3% -33.2% 14.5% -3.2%
Q3 - - -8.6% 172% -50.6% 8% -27.2% 47.5% 7% -
Q4 - -15.7% 39.7% -10.5% 60.3% 49.4% -24.2% -53.4% 36.4% -
J F M A M J J A S O N D
2024 28.7% -13.4% -13.1% -6.9% - - - - - - - -
2023 17.8% -7.9% 7.2% 8.5% 14.3% -7.7% 12.2% 7.4% -11.2% -11.8% -0.6% 45.1%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%38%103%-9%3%-29%-49%81%-23%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 7.38 0.25 - -0.49 -0.23 -0.52 -0.56 -0.92 -0.75
Q2 0.37 0.28 0.43 -0.03 -0.46 -0.37 -0.67 -0.98 -0.74
Q3 0.19 0.09 0.51 -0.47 -0.42 -0.61 -0.66 -0.94 -0.74
Q4 - - 0.50 -0.22 -0.33 -0.58 -0.8 -0.90 -0.80
A 7.9 0.6 1.4 -1.2 -1.6 -2.4 -3.4 -3.3 -3.03

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2017 2018 2019 2020 2021 2022
Mar - 10.8 17.2 17.8 24.3 24.5
Jun - - - 17.8 - -
Sep 9.7 17.2 17.8 17.9 24.4 24.6
Dec 10.8 17.2 17.8 17.9 24.5 24.6

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - 6.5 8 4.2
Total Asset Turnover - - 0.1 0.1 0.1
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 6.5 4.8 3.4 3.3 6.5
Equity multiplier - - - - 0.1